Vulvodynia: What you need to know


Vulvodynia and vestibulodynia refer to a chronic discomfort of the vulva, the part of a woman’s body that protects the genitals.

It includes the external female genitalia, including the mons pubis, the labia majora and minora, the clitoris, and the perineum.

Vulval pain can happen for a number of reasons, but vulvodynia and vestibulodynia are specifically linked to a hypersensitivity of the nerve endings in the skin.

Around 16 percent of women are estimated to have experienced pain or stinging in the vulval area at some time in their life.

Treatment

Treatment aims to alleviate symptoms. As the cause is unknown, finding a solution that works may take some trial and error.

Medications to block pain may include antidepressants, anticonvulsants, or serotonin-norepinephrine reuptake inhibitors (SNRIs).

Other solutions include creams, lotions, and anesthetic gel for applying to the vulval area.

Examples include topical hormone creams containing estrogen and testosterone, topical anesthetics, such as lidocaine, and products that contain an antidepressant or anticonvulsant ingredient. These can be applied 15 to 20 minutes before sexual activity, or when needed. Some of these products are available for purchase online, including lidocaine.

A nerve block is an anesthetic drug that is injected into the nerves that transmit pain signals, in this case, from the vulva to the spine. Interrupting the pain signals in this way can provide short-term relief.

If no other method is effective, surgery to remove the painful tissue may be appropriate.

Two techniques that are currently being investigated are neurostimulation and the spinal infusion pump.

Neurostimulation involves delivering low-voltage electrical stimulation to a specific nerve. This can replace pain with a tingling sensation.

A spinal infusion pump is an implanted device that can deliver low-dose medication to the spinal cord and nerve roots. This can dull pain.

However, there is limited evidence regarding the use of these measures for vulvodynia.

Some researchers have found that physical and psychosexual therapy can help improve sexual functioning, for example, by helping to reverse a fear of touch.

Symptoms

Vulvodynia features a burning, stinging, itching, irritating, or a raw feeling in the vulvar tissue, which may or may not appear inflamed. Patients may describe a feeling of throbbing, itching, aching, soreness, and swelling.

The pain can affect a particular spot, or it may be felt in a wider area, including the clitoris, the perineum, the mons pubis, and the inner thighs. It can also affect the area around the urethra and the top of the legs and inner thighs.

The pain involved in vulvodynia is neuropathic, which means it stems from abnormal signals from the nerve fibers in the vulval area. The nerve endings are hypersensitive.

It may be constant or intermittent. A constant pain that happens when there is no touch or pressure is known as unprovoked vulvodynia.

Vestibulodynia, previously known as vestibulitis, involves a pain that is triggered by light touch, or provoked pain.

Symptoms may be worse during or after sexual intercourse, walking, sitting, or exercising. It can happen when inserting a tampon, or when prolonged pressure is applied, for example, during horseback riding.

Vulvodynia is usually defined as lasting for at least 3 months. It often starts suddenly, and it may last for months or years. It is not life-threatening, but the pain can prevent the individual from carrying out some normal activities. This can also lead to upset or depression.

Complications

Relationship problems can result, because sexual intercourse is painful. One study suggests that 60 percent of women with vulvodynia are unable to engage in sex.

Studies suggest

that women who have vulvodynia can have a normal pregnancy, and that in some cases, pain levels fall during pregnancy. However, women with the condition are more likely to have a cesarean delivery.

Home remedies

Some measures can be taken that do not involve medications.

If vulvodynia occurs, the first step is to stop using any irritants, such as perfumed soaps. A change in menstrual products might help, for example, switching from synthetic to cotton-based items.

Cool gel packs may offer immediate, short-term pain relief. A range of cool gel packs is available for purchase online.

Pelvic floor muscle exercises may help by relaxing tissues in the pelvic floor and releasing tension in muscles and joints.

Biofeedback uses technology to increase an individual’s awareness of how they might be stressing their body. This information can help people change habits that lead to harm or discomfort. For women with vulvodynia, it can help strengthen the pelvic floor muscles, and this may reduce pain.

A trigger point is a specific area of discomfort. Trigger-point therapy involves massaging a small area of tightly contracted muscle to release tension and relieve pain. An anesthetic medication applied directly, for example, as a cream, can also be used to relieve pain in a trigger point.

Since stress can play a role in vulvodynia, either as a trigger or a consequence, stress management may help ease symptoms.

Acupuncture and cognitive behavior therapy are options currently being explored.

Diet

A change in diet may help. Cutting out one food at a time may help to pinpoint a trigger.

Items that commonly trigger a reaction include:

  • caffeine
  • high-sugar foods
  • acidic foods
  • processed foods

Causes

Vulvar pain can be caused by infections, neurological problems, inflammatory conditions, and neoplasms, such as squamous cell carcinoma.

Vulvodynia is not related to an underlying condition. The exact cause is unknown. It is not caused by a sexually transmitted or other infection, skin disease, or cancer, although these can also cause pain.

Factors that may raise the risk of vulvodynia include:

  • Damage to or irritation of the nerves around the vulva
  • A high density of pain-sensing nerve fibers in the vulval area
  • High levels of inflammatory substances in the vulval area, for example, because of inflammation
  • genetic susceptibility
  • pelvic floor muscles are weak or unstable
  • unusual or long-term reaction to infection, trauma, or another environmental factor
  • changes triggered by hormones

Other factors that increase susceptibility include:

  • frequent yeast infections
  • sexually transmitted infections (STIs)
  • chemical irritation of the external genitals, caused by soaps, feminine hygiene products or detergents in clothing
  • rashes on the genital area
  • previous laser treatments or surgery on the external genitals
  • nerve irritation, injury or muscle spasms in the pelvic area
  • diabetes
  • precancerous or cancerous conditions on the cervix

Provoked vestibulodynia could result from:

  • sexual intercourse
  • tampon insertion
  • a gynecologic examination
  • prolonged sitting
  • wearing tight underclothes or pants
  • activities such as cycling or horseback riding

Clitorodynia refers to pain in the clitoris.

Vulvodynia can be confused with other vulvovaginal problems, such as chronic tension or spasm of the muscles of the vulvar area called vaginismus.

Prevention

Measures that can reduce the risk of triggering pain include:

  • wearing cotton underwear and loose-fitting clothes around the genital area
  • avoiding scented toilet paper and perfumed creams and soaps
  • avoiding friction or sitting for prolonged periods
  • refraining from excessive genital washing
  • not douching or using vaginal wipes
  • using water-soluble lubricants during sexual intercourse
  • patting the area dry after rinsing or urinating

If a vaginal infection is suspected, it is important to have it diagnosed and treated promptly and to discuss with a physician if any treatments appear to make the condition worse.

Diagnosis

Diagnosis may involve a pelvic exam, to look for skin changes and assess the pain.

A cotton swab test is used to delineate the areas of pain and categorize their severity. The physician may press with swab on different areas while asking the patient to rate the level of pain.

The patient should be ready to describe the pain, including the type of pain and its severity, say when it started, and whether it began gradually or suddenly, where it hurts, and how often.

The doctor may use a special magnifying glass, to carry out a colposcopy.

Tests may be carried out to try to find the source of the pain and to eliminate other causes.

These include:

  • taking a culture for bacteria and yeast
  • blood tests to assess levels of estrogen, progesterone, and testosterone
  • a biopsy

In a biopsy, the doctor first numbs the genital area with a painkiller, and then a small piece of tissue is taken for examination under a microscope.

Insomnia: Everything you need to know


Insomnia is a sleep disorder that regularly affects millions of people worldwide. In short, individuals with insomnia find it difficult to fall asleep or stay asleep. The effects can be devastating.

Insomnia commonly leads to daytime sleepiness, lethargy, and a general feeling of being unwell, both mentally and physically. Mood swings, irritability, and anxiety are common associated symptoms.

Insomnia has also been associated with a higher risk of developing chronic diseases. According to the National Sleep Foundation, 30-40 percent of American adults report that they have had symptoms of insomnia within the last 12 months, and 10-15 percent of adults claim to have chronic insomnia.

Here, we will discuss what insomnia is, its causes, symptoms, diagnosis, and possible treatments.

Fast facts on insomnia:

  • There are many possible causes of insomnia.
  • An estimated 30-40 percent of Americans report experiencing insomnia each year.
  • Often, insomnia is due to a secondary cause, such as illness or lifestyle.
  • Causes of insomnia include psychological factors, medications, and hormone levels.
  • Treatments for insomnia can be medical or behavioral.

Causes

Insomnia can be caused by physical and psychological factors. There is sometimes an underlying medical condition that causes chronic insomnia, while transient insomnia may be due to a recent event or occurrence. Insomnia is commonly caused by:

  • Disruptions in circadian rhythm – jet lag, job shift changes, high altitudes, environmental noise, extreme heat or cold.
  • Psychological issues – bipolar disorder, depression, anxiety disorders, or psychotic disorders.
  • Medical conditions – chronic pain, chronic fatigue syndrome, congestive heart failure, angina, acid-reflux disease (GERD), chronic obstructive pulmonary disease, asthma, sleep apnea, Parkinson’s and Alzheimer’s diseases, hyperthyroidism, arthritis, brain lesions, tumors, stroke.
  • Hormones – estrogen, hormone shifts during menstruation.
  • Other factors – sleeping next to a snoring partner, parasites, genetic conditions, overactive mind, pregnancy.

Media technology in the bedroom

Several small studies in adults and children have suggested that an exposure to light from televisions and smartphones prior to going to sleep can affect natural melatonin levels and lead to increased time to sleep.

In addition, a study conducted by Rensselaer Polytechnic Institute found that backlit tablet computers can affect sleep patterns. These studies suggest that technology in the bedroom can worsen insomnia, leading to more complications.

Medications

According to the American Association of Retired Persons (AARP), the following medications can cause insomnia in some patients:

  • corticosteroids
  • statins
  • alpha blockers
  • beta blockers
  • SSRI antidepressants
  • ACE inhibitors
  • ARBs (angiotensin II-receptor blockers)
  • cholinesterase inhibitors
  • second generation (non-sedating) H1 agonists
  • glucosamine/chondroitin

Signs and symptoms

Insomnia itself may be a symptom of an underlying medical condition. However, there are many signs and symptoms that are associated with insomnia:

  • Difficulty falling asleep at night.
  • Waking during the night.
  • Waking earlier than desired.
  • Still feeling tired after a night’s sleep.
  • Daytime fatigue or sleepiness.
  • Irritability, depression, or anxiety.
  • Poor concentration and focus.
  • Being uncoordinated, an increase in errors or accidents.
  • Tension headaches (feels like a tight band around head).
  • Difficulty socializing.
  • Gastrointestinal symptoms.
  • Worrying about sleeping.

Sleep deprivation can cause other symptoms. The afflicted person may wake up not feeling fully awake and refreshed, and may have a sensation of tiredness and sleepiness throughout the day.

Having problems concentrating and focusing on tasks is common for people with insomnia. According to the National Heart, Lung, and Blood Institute, 20 percent

Types

Insomnia includes a wide range of sleeping disorders, from lack of sleep quality to lack of sleep quantity. Insomnia is commonly separated into three types:

  • Transient insomnia – occurs when symptoms last up to three nights.
  • Acute insomnia – also called short-term insomnia. Symptoms persist for several weeks.
  • Chronic insomnia – this type lasts for months, and sometimes years. According to the National Institutes of HealthTrusted Source
    , the majority of chronic insomnia cases are side effects resulting from another primary problem.

Treatment

Good sleep hygiene, including avoiding electronics before bed, can help treat insomnia.

Some types of insomnia resolve when the underlying cause is treated or wears off. In general, insomnia treatment focuses on determining the cause.

Once identified, this underlying cause can be properly treated or corrected.

In addition to treating the underlying cause of insomnia, both medical and non-pharmacological (behavioral) treatments may be used as therapies.

Non-pharmacological approaches include cognitive behaviorlal therapy (CBT) in one-on-one counseling sessions or group therapy:

Medical treatments for insomnia include:

  • prescription sleeping pills
  • antidepressants
  • sleep aids available online or over-the-counter
  • antihistamines
  • melatonin, which can be purchased online
  • ramelteon

Home remedies

Home remedies for insomnia include:

  • Improving “sleep hygiene”: Not sleeping too much or too little, exercising daily, not forcing sleep, maintaining a regular sleep schedule, avoiding caffeine at night, avoiding smoking, avoiding going to bed hungry, and ensuring a comfortable sleeping environment.
  • Using relaxation techniques: Examples include meditation and muscle relaxation.
  • Stimulus control therapy – only go to bed when sleepy. Avoid watching TV, reading, eating, or worrying in bed. Set an alarm for the same time every morning (even weekends) and avoid long daytime naps.
  • Sleep restriction: Decreasing the time spent in bed and partially depriving the body of sleep can increase tiredness, ready for the next night.

Diagnosis

A sleep specialist will start by asking questions about the individual’s medical history and sleep patterns.

A physical exam may be conducted to look for possible underlying conditions. The doctor might screen for psychiatric disorders and drug and alcohol use.

The Stanford Center for Sleep Sciences and Medicine explains that the term “insomnia” is often used to refer to “disturbed sleep.”

For a diagnosis of insomnia, the disturbed sleep should have lasted for more than 1 month. It should also negatively impact the patient’s wellbeing, either through the causing distress or disturbing mood or performance.

The patient may be asked to keep a sleep diary to help understand their sleeping patterns.

Other tests may include a polysomnograph. This is an overnight sleeping test that records sleep patterns. In addition, actigraphy may be conducted. This uses a small, wrist-worn device called an actigraph to measure movement and sleep-wake patterns.

Risk factors

Insomnia can affect people of any age; it is more common in adult females

than adult males. It can undermine school and work performance, as well as contributing to obesity, anxiety, depression, irritability, concentration problems, memory problems, poor immune system function, and reduced reaction time.

Some people are more likely to experience insomnia. These include:

  • travelers, particularly through multiple time zones
  • shift workers with frequent changes in shifts (day vs. night)
  • the elderly
  • users of illegal drugs
  • adolescent or young adult students
  • pregnant women
  • menopausal women
  • those with mental health disorders

Flu rash: Everything you need to know


The flu is a common respiratory infection, and its symptoms can range from mild to severe. Although a rash is not a common symptom of the flu, it can sometimes occur.

There is evidence to suggest that certain types of flu may lead to a rash forming in some people. In other cases, another condition may cause a rash to develop when a person has the flu.

In this article, learn more about a flu rash, including the symptoms, diagnosis, and treatment.

Can the flu cause a rash?

The flu causes many uncomfortable symptoms, but a rash is typically not one of them. There is some evidence, however, that the flu may sometimes cause a rash.

A small 2014 case study

of school-aged children found that a rash is a possible symptom of influenza type B.

The authors indicated that other factors, aside from the flu, might have contributed to the onset of the rash, such as a measles outbreak in a nearby area.

The authors of an older article

from 2011 stated that a rash occurs in about 2% of all influenza A cases. The researchers indicated that the rash could occur among children with or without accompanying viral or bacterial infections or environmental factors.

Other symptoms

The flu has several recognizable symptoms that a person will typically experience during the infection.

In most cases, the flu will clear on its own within a few days to 2 weeks

According to the Centers for Disease Control and Prevention (CDC)

, the typical symptoms of the flu include:

  • a cough
  • chills
  • a fever
  • body aches
  • a sore throat
  • fatigue
  • a stuffy or runny nose
  • headaches
  • vomiting or diarrhea

In some cases, a person may develop health complications as a result of the flu. Some of these, such as pneumonia, can be life threatening.

Other complications may include:

  • worsened asthma symptoms
  • swelling of heart, brain, or muscle tissues
  • heart or kidney failure
  • extreme inflammatory responses in the body

Other causes of a rash

Certain other viruses could potentially cause a rash. Some of these viruses may have symptoms similar to those of the flu and be easy to mistake for this illness at first.

For example, a person may develop flu-like symptoms prior to developing a measles rash.

Some common measles symptoms that may appear before the rash occurs include:

  • a runny nose
  • a fever
  • fatigue
  • a cough
  • body aches and pains

Some other common viral infections that may cause a rash include:

  • chickenpox
  • rubella
  • fifth disease
  • roseola
  • West Nile virus
  • dengue fever
  • hand, foot, and mouth disease
  • mononucleosis
  • Zika virus

In some cases, another condition may cause a rash in someone who already has the flu.

Diagnosis

If flu-like symptoms occur alongside a rash, it is best to speak to a doctor. During the appointment, the doctor will conduct a physical examination and ask about the person’s symptoms.

During times when the flu is widespread, the doctor may not need to test for the virus. However, when this is not the case, the doctor may test for the type of virus.

A doctor can also examine the rash and determine whether it may be due to a different condition.

Treatment

If a person has the flu, the typical treatment involves extra rest and fluids. However, people with severe infections and those at risk of developing complications may receive antiviral medications from a doctor.

These medications can help the person recover from their flu more quickly and prevent further complications. Some examples include:

  • peramivir (Rapivab)
  • oseltamivir (Tamiflu)
  • baloxavir (Xofluza)
  • zanamivir (Relenza)

If a person has the flu and a rash, a doctor may not treat the rash directly. Instead, the rash should clear when the body fights off the virus.

3 Foods Dogs Shouldn’t Eat

What’s missing in most dog food? Get this top US vet’s dog food topper to help

longevity. – NutraThrive

When to see a doctor

Anyone can develop the flu, even otherwise healthy individuals. However, certain groups of people have a higher risk of developing complications. These individuals include:

  • older people
  • children under the age of 5 years
  • pregnant women
  • people with chronic illnesses, such as asthma, diabetes, or heart disease

Although most cases of the flu will resolve with plenty of rest and fluids, people who are at risk of complications should see a doctor.

In some cases, a person may need to seek immediate medical attention. People with the flu should seek emergency medical care if they experience any of the following:

  • persistent pain or pressure in the chest or abdomen
  • difficulty breathing
  • seizures
  • severe muscle pain
  • shortness of breath
  • a fever or cough that improves but then returns or worsens
  • persistent confusion or dizziness
  • worsening of chronic medical conditions
  • lack of urination
  • severe weakness or unsteadiness

Parents or caregivers should seek emergency care

for a child who has:

  • bluish lips or face
  • severe muscle pain
  • fast breathing or trouble breathing
  • seizures
  • ribs pulling in with each breath
  • chest pain
  • a fever or cough that improves before returning or worsening
  • dehydration, signs of which can include little urine, no tears, and a dry mouth
  • a lack of alertness
  • the inability to interact when awake
  • a fever above 104°F or any fever in infants under 12 weeks old
  • worsening symptoms of chronic medical conditions

Summary

A rash is a possible but uncommon symptom of the flu. If a rash appears due to the flu or another virus, it should clear when the virus is no longer active.

A person should see their doctor if they have an unexplained rash or severe flu symptoms. A doctor can also help determine whether the rash is due to the flu or another condition.

Rare diseases more common than we think

Rare diseases are by their very nature obscure and unknown, falling through the cracks when it comes to research budgets and treatment development. But now, a study has shown they are more common than we think.

The United States classifies a rare disease as one that affects fewer than 200,000 people. However, all together, rare diseases in the U.S. affect 25–30 million people.

While the diseases themselves may be rare, this significant figure highlights just how many people are living with diseases that get little attention due to their singularity.

Until the recent study, scientists had no real concept of the prevalence of rare diseases globally.

The few studies into the incidence of rare diseases have seldom looked at population registries, making it hard to establish prevalence with precision.

As in the U.S., most countries do not track rare diseases. In fact, they document very few even after diagnosis. This makes it tricky to work out the exact number of rare diseases or how many people are living with them.

Now an analysis of the Orphanet database, which is a comprehensive record of the incidence of rare disease, indicates that over 300 million people globally are living with a rare disease.

‘A low estimation of the reality’

“In all likelihood, our data represent a low estimation of the reality. The majority of rare diseases are not traceable in healthcare systems, and in many countries, there are no national registries,” says Ana Rath, the director of Inserm US14 in Paris, France.

The National Institute for Health and Medical Research (INSERM) in France established Orphanet in 1997 to improve knowledge of rare diseases and boost awareness, diagnosis, and treatment of people living with them.

Today, a consortium of 40 countries work together to pool data on rare diseases, making it the most comprehensive source of data on the topic.

Researchers hope that by highlighting the number of individuals impacted by a rare disease and showing that rare disease is “not so rare,” public health policies at a national and global level will begin to address the issue.

“Given that little is known about rare diseases, we could be forgiven for thinking that [those living with them] are thin on the ground,” says Rath. “But when taken together, they represent a large proportion of the population.”

According to the Genetic and Rare Diseases Information Center (GARD), there may be as many as 7,000 rare diseases. Experts often refer to these diseases as orphan diseases because drug companies have tended to neglect them by excluding them from their drug research and treatment development budgets.

59c5868a-e086-4e89-886a-6d584c7dc3dc.gif

, which passed in the U.S. in 1983, offered pharmaceutical companies a financial incentive to develop drugs for rare diseases, such as polycythemia vera, Marfan syndrome, and systemic sclerosis.

However, there is still no available treatment for most rare diseases.

Many scientists have serious concerns about the impact that these rare diseases have on those living with them and their families around the world.

4% of the population have a rare disease

The researchers did not include some cancers or other rare conditions induced by infection or poisoning in their investigation. However, they analyzed 3,585 rare diseases to find out how many people globally have the disease at the same time. The results showed that 3.5­–5.9% of the world’s population have these conditions at any given time.

The study also found that 80% of those with a rare disease had one of only 149 illnesses.

In addition, 71.9% of the diseases on Orphanet had genetic causes, and 69.9% began in childhood.

The research concludes that rare diseases are not so rare, after all.

In the study abstract, the authors refer to rare diseases as “an emerging global public health priority.”

The researchers call for the findings to shine a light on research priorities, emphasize the societal impact of these conditions, and highlight the need for a comprehensive public health policy, both on a national and global level.

The focus going forward is on examining those diseases not included in the study and building knowledge on rare diseases to ensure that people receive better care.

“Making patients visible within their respective healthcare systems by implementing means to record their precise diagnoses would make it possible in the future not only to review our estimations but more fundamentally to improve the adaptation of support and reimbursement policies.”

Ana Rath

In the U.S., the Office of Orphan Products Development (OOPD)

runs a program to incentivize drug companies to develop treatments for rare diseases. The 10 years between 1973 and 1983 saw the approval of just 10 treatments for rare diseases. But since then, the OOPD have overseen the development of more than 400 drugs and products.

New technology better controls type 1 diabetes

Type 1 diabetes has no cure, and although there are several treatment options available, many people find managing the condition challenging. New technology could help reduce that burden.

Many people find managing type 1 diabetes inconvenient, but new research may change this.

More than 1 million children and adults in the United States have type 1 diabetes, according to the American Diabetes Association. 

The Centers for Disease Control and Prevention (CDC) note that about 5%

Trusted Source

of all people who have diabetes have type 1. 

Type 1 diabetes can significantly impact a person’s life, as people need to monitor their blood sugar levels regularly to ensure they do not become dangerously high or low.

Currently, people with type 1 diabetes measure their blood sugar levels by pricking a finger several times a day or wearing a glucose monitor. Depending on the measurements, they may have to administer insulin using an injection or insulin pump.

But a new form of technology trialed recently and showcased in the New England Journal of Medicine could replace these conventional methods.

Automatic insulin

The trial looked at a particular type of artificial pancreas, or closed-loop control. These devices continuously monitor and regulate blood glucose levels. When the monitor detects that a person needs insulin, a pump releases the hormone into the body. 

The trial involved the use of the Control-IQ system — a new type of artificial pancreas that uses algorithms to adjust insulin doses automatically throughout the day.

“By making management of type 1 diabetes easier and more precise, this technology could reduce the daily burden of this disease, while also potentially reducing diabetes complications, including eye, nerve, and kidney diseases,” says Dr. Griffin P. Rodgers, director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

The 6-month trial is part of a much larger research initiative known as the International Diabetes Closed-Loop (iDCL) Study, which involves the testing of several artificial pancreas systems to determine a variety of factors, such as safety, effectiveness, and user-friendliness.

The trial recruited 168 people with type 1 diabetes and with a minimum age of 14.

The researchers assigned over 100 people to use the Control-IQ system, while 56 people formed a control group that used sensor-augmented pump (SAP) therapy. This therapy does not alter insulin doses automatically.

Researchers wanted to replicate day-to-day life, so they did not monitor the systems remotely. Participants did, however, contact researchers every few weeks to check data from the device.

24-hour control

The researchers were interested in the amount of time that blood glucose levels reached a target range of 70 to 180 milligrams per deciliter (mg/dl).

The results showed that the blood sugar levels of the people who used the Control-IQ system were in the target range for an average of 2.6 hours per day longer than previously. Those using the SAP therapy saw no notable change throughout the trial.

Vitally, the system also improved the participants’ blood glucose control overnight as well as during the day. This is a crucial advancement for people whose levels drop significantly when asleep.

None of the groups experienced severe cases of hypoglycemia ⁠— when blood sugar levels become very low.

Reducing the burden

According to Dr. Guillermo Arreaza-Rubín, the study’s program scientist and director of NIDDK’s Diabetes Technology Program, these findings indicate that this system “has the potential to improve the health of people living with type 1 diabetes, while also potentially lifting much of the burden of care from those with the disease and their caregivers.”

Boris Kovatchev, Ph.D., director of the UVA Center for Diabetes Technology, says the technology’s glucose control is “beyond what is achievable using traditional methods.”

The team has submitted the results of the trial to the U.S. Food and Drug Administration (FDA). They are waiting to find out whether the device can go to market.

Doctors’ beliefs about treatment affect patients’ experience of pain


New research finds that the placebo effect may be socially contagious. In other words, a doctor’s beliefs about whether or not a pain treatment will work can exert a subtle influence on how much pain the patient will actually experience. 

A doctor’s display of confidence in a treatment may make it more effective.

The power of placebo may extend beyond what researchers previously believed.

At first, they only used placebos as controls in drug experiments.

With time, however, placebos proved to have value as potential treatments in their own right.

Pain, depression, anxiety, irritable bowel syndrome, Parkinson’s disease, and epilepsy are only some of the conditions that placebos have shown promise in treating.

A new study has looked into another fascinating aspect of the placebo: Does it transmit socially, from one person to another? If so, how? More specifically, how does a doctor’s belief about the effects of a medication affect their patient’s experience of pain?

Laboratory at Dartmouth College in Hanover, NH — is the corresponding author of the new study.

Chang and colleagues have published their findings in the journal Nature Human Behaviour

Testing placebo power in 3 experiments

To study the phenomenon of socially transmitted placebo, the researchers devised three experiments. All three involved two different creams that were meant to relieve heat-induced pain by targeting pain receptors on the participants’ skin.

One of the creams was called thermedol, and the other was a control cream. Although different in appearance, both creams were actually placebos — namely, petroleum jelly with no pain relieving properties at all.

The researchers asked undergraduate students to play the roles of “doctors” and “patients.” They informed the “doctors” of the creams’ benefits and conditioned them to believe that thermedol was better at relieving pain than the control cream.

The first experiment consisted of 24 “doctor-patient” pairs. In each pair, the “patient” did not know which cream was thermedol and which was the control. Only the “doctor” knew which was the “effective” cream.

The researchers then applied the creams to the participants’ arms, followed by pain-inducing heat, in order to evaluate the effects of the cream. All participants received the same amount of heat.

During the experiment, all participants wore cameras that recorded their facial expressions in the doctor-patient interactions.

Using a machine-learning algorithm trained on facial signals of pain, the researchers were able to examine the effect of cues such as raised eyebrows, raised upper lips, or nose wrinkling on the perceived effectiveness of the treatments.

In this experiment, the participants reported experiencing less pain with thermedol, and skin conductance tests suggested that they actually did experience less discomfort. Their facial expressions also reflected less pain with thermedol.

In the other two experiments, the researchers applied the creams in different orders, and they led the doctors to believe that they were using thermedol when they were using the control creams, and vice versa.

The experimenters themselves were also blind to the study, not knowing which cream was which. In these experiments, the results were the same.

How doctors’ beliefs affect clinical results

Overall, across all three experiments, the results revealed that when the “doctors” believed that a treatment was effective, the “patients” reported feeling less pain. Their facial expressions and skin conductance tests also revealed fewer signs of pain.

The reasons for this remain unclear. However, the researchers believe that social contagion via facial cues is the most likely explanation.

“When the doctor thought that the treatment was going to work, the patient reported feeling that the doctor was more empathetic,” says Chang.

“The doctor may have come across as warmer or more attentive. Yet, we don’t know exactly what the doctor was doing differently to convey these beliefs that a treatment works. That’s the next thing that we’re going to explore,” he adds.

“What we do know though is that these expectations are not being conveyed verbally but through subtle social cues,” explains Chang.

“These findings demonstrate how subtle social interactions can impact clinical outcomes. You can imagine that in a real clinical context, if the healthcare providers seemed competent, empathetic, and confident that a treatment may work, the impact on patient outcomes could be even stronger.”

Balancing work and family life puts a strain on women’s heart health.

Researchers believe that stress and cardiovascular health are linked in some way, but the association is not yet fully clear. A large-scale new study has recently delved into the effects of a unique kind of stress.

According to the American Heart Association (AHA), stress may affect factors that increase the risk of heart disease, including blood pressure and cholesterol level.

One major source of stress is the workplace.

In fact, a 2015 review of 27 studies that appeared in the journal Current Cardiology Reports

found an association between work stress and a “moderately elevated risk of incident coronary heart disease and stroke.”

However, one type of stress that researchers often leave out of studies is that felt by a person who needs to simultaneously balance the demands of work and family life.

Examining this in more depth may eventually help health professionals better identify and treat cardiovascular issues. This is according to the authors of the new study, which now appears in the Journal of the American Heart Association.

What is work-family conflict?

Cardiovascular diseases are currently the leading cause of death worldwide, say the World Health Organization (WHO).

Health professionals can determine people’s cardiovascular health score. Based on seven metrics including diet, blood pressure, and physical activity levels, the researchers who conducted the new study used this score to investigate how work and family stress can impact heart health.

According to the study paper, work-family conflict refers to “a form of inter-role conflict in which the role pressures from the work and family domains are mutually incompatible in some respect.”

More than 11,000 workers ages 35–74, from six state capitals in Brazil, made up the study’s sample. The participants came from a variety of educational and work backgrounds, and the study included a slightly higher number of women.

Each participant filled out a questionnaire to determine how their job affected their family life, and how their family life impacted their work.

The researchers calculated the participants’ cardiovascular health scores using a combination of clinical examinations, laboratory test results, and self-reported questionnaires.

An unequal impact

The analysis showed a distinct sex difference. Men reported less work interference with family and more time for personal care and leisure. Both sexes reported a similar amount of family interference with work.

However, women appeared to be worse off. Those who reported a number of frequent work-family conflicts had lower cardiovascular health scores.

“This was interesting because in our previous study, job stress alone affected men and women almost equally,” says senior study author Dr. Itamar Santos, a professor at the University of São Paulo in Brazil.

There could be a simple explanation as to why this is the case, and it has to do with traditional gender roles. “You feel the stress to fulfill the gender roles, and I think women still feel more of a need to have that nurturing home life,” says Dr. Gina Price Lundberg, clinical director of the Emory Women’s Heart Center in Atlanta, GA.

“Men are helping more than ever, but I think working women still feel the stress of trying to do it all.” She goes on to describe the study as “well-designed,” due to its large sample size, the diverse background of the participants, and the balance of men and women.

However, certain elements of the study relied on the participants’ own thoughts and feelings, which may have biased the results.

How to live with stress

What this study has dipped into is the need for a good work-life balance. However, this is easier said than done in many cases.

Dr. Santos hopes that the new findings will encourage workplaces to introduce stress reducing initiatives and encourage doctors to look for signs of stress when examining people.

“We’re not going to eliminate stress,” Dr. Santos says. “But we should learn how to live with it to not have so many bad consequences.”

Whether that would be through measures such as at-home meditation or employer-led strategies is yet to be determined.

Dr. Santos and team are now planning to follow the same participants for up to a decade to gain further insight.

A simple blood test could make a great difference for those with brain cancer.

New blood test detects brain tumors with 87% accuracy

Dr. Matthew J. Baker, a reader in the Department of Pure and Applied Chemistry at the University of Strathclyde in Glasgow, United Kingdom, is the lead author of the new research.

He and his colleagues have now published their findings in the journal Nature Communications.

Of the study, Dr. Baker says, “This is the first publication of data from our clinical feasibility study, and it is the first demonstration that our blood test works in the clinic.”

Although it is quite rare, brain cancer often has a poor outlook.

According to the National Cancer Institute, around 0.6% of people will develop brain cancer or another cancer of the nervous system in their lifetime.

However, the 5 year survival rate for those who do receive such a diagnosis is less than 33%.

Largely, the poor outlook is due to the fact that brain tumors have very nonspecific symptoms, which makes them more difficult to distinguish from other conditions.

Study co-author Dr. Paul Brennan — a senior clinical lecturer and consultant neurosurgeon at the University of Edinburgh in the U.K. — explains, “Diagnosing brain tumors is difficult, leading to delays and frustration for lots of people.”

“The problem is that symptoms of brain tumor are quite nonspecific, such as headache, or memory problems. It can be difficult for doctors to tell which people are most likely to have a brain tumor,” he adds.

The lack of cost effective tests that can help doctors triage people with brain tumors in primary care also means that it takes longer to accurately diagnose brain cancer. This ultimately results in a poorer outlook.

The team’s new blood test brings much needed hope in this regard. Dr. Baker and colleagues used infrared light to create a “bio-signature” of people’s blood samples and applied artificial intelligence to scan for signs of cancer.

The test correctly identified brain cancer in a cohort of 104 people 87% of the time.

A more rapid means of diagnosis

As the researchers explain in their paper, they used a technique called attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy and coupled it with machine learning technology to detect brain cancer.

The authors explain that the technique is “a simple, label free, noninvasive, nondestructive” way of analyzing the biochemical profile of a blood sample without requiring extensive preparation of the sample.

The ATR-FTIR technique allowed the researchers to work out a biochemical “fingerprint” of brain cancer.

Dr. Baker and team trained a machine learning algorithm to use these biochemical fingerprints to diagnose brain cancer in a retrospective cohort of 724 people. This cohort included people with primary and secondary cancers as well as control participants without cancer.

They then used the algorithm to predict brain cancer cases in a sample of 104 participants. Of these, 12 people had cancer, including four cases of glioblastoma. This is one of the most aggressive forms of brain tumor.

The findings revealed a sensitivity of 83.3% and a specificity of 87% for the blood test. “With this new test, we have shown that we can help doctors quickly identify which [people] with these nonspecific symptoms should be prioritized for urgent brain imaging,” says Dr. Brennan.

“This,” he adds, “means a more rapid diagnosis for people with a brain tumor, and quicker access to treatment.”

Hayley Smith — an ambassador for the Brain Tumor Charity in Hampshire, U.K. — adds that it is “very encouraging to hear that this blood test can lead to a quicker diagnosis for brain cancer.”

“This kind of test will be vital to patients, helping people to get the correct diagnosis quicker, which ultimately will help people to get the urgent medical care that they need.”

What to know about spotting in early pregnancy

Spotting in early pregnancy is common for many women and usually not a cause for concern. However, in some instances, it may occur as a symptom of a pregnancy complication.

About a quarter of pregnant women experience bleeding during the first trimester. Although bleeding is a possible sign of early pregnancy loss, it does not mean that this will happen. Several other conditions and factors, including normal hormonal shifts, may cause spotting in early pregnancy.

Causes

The most common causes of spotting in early pregnancy include:

Subchorionic hematoma

A subchorionic hematoma is sometimes called subchorionic hemorrhage. This happens when blood builds up near the chorion, which is the fetal membrane next to the placenta. The bleeding may also appear between the uterus and the placenta.

Subchorionic hematoma is a common pregnancy complication with various studies estimating the prevalence between 1.3% and 62% among different groups of pregnant women.

A subchorionic hematoma is not a pregnancy loss. Many pregnant women with this type of bleeding have no further complications during their pregnancy.

A 2012 meta-analysis of nine research studies concluded that there was a link between subchorionic hemorrhage and higher risk of pregnancy loss and preterm labor.

However, a 2013 observational study of 1,115 women that included 142 with a subchorionic hematoma found no significant increase in the risk of pregnancy complications.

Ectopic pregnancy

In an ectopic pregnancy, a fertilized egg implants outside of the uterus, often in the fallopian tubes. A woman may still have pregnancy symptoms or get a positive pregnancy test. The pregnancy, however, cannot survive. If it continues to grow, it can rupture and cause life threatening bleeding or a dangerous infection.

An ectopic pregnancy can cause spotting as the pregnancy grows. If the pregnancy ruptures, it can cause life threatening internal bleeding that may get progressively heavier over several hours.

Cervical irritation

The cervix, the doughnut-shaped entry to the uterus, increases its blood supply during pregnancy. This means it is more likely to bleed from irritation, such as after sex or a pelvic exam. Light spotting after any form of vaginal penetration is a possible sign of cervical bleeding.

Cervical bleeding is not dangerous and usually stops on its own within a few hours. The blood is typically red or brown, and the bleeding minimal.

Very rarely, a serious injury to the cervix, such as from an assault or trauma, might cause more severe cervical bleeding. These injuries can cause infections and other serious complications. It is important to see a doctor following any traumatic injury to the cervix or vagina.

Pregnancy loss

For many pregnant women, bleeding triggers fears of pregnancy loss. A 2010 study of 4,539 pregnant women found that 26.7% experienced bleeding at some point during their pregnancies, but only 12% had a pregnancy loss. These figures suggest that less than half of people who bleed during pregnancy have a pregnancy loss.

About two-thirds of people who do have a pregnancy loss report bleeding. As such, bleeding is a symptom that a pregnant person should not ignore. Any pregnant woman who has concerns about their pregnancy should speak to a doctor about risk factors and how to minimize them.

Hormonal shifts

Around the 7th week of pregnancy, a luteal-placental shift happens. This is when the placenta develops enough to begin producing hormones that sustain the pregnancy. Before this change, the corpus luteum — a group of cells that forms during ovulation — produces pregnancy hormones.

This hormonal change sometimes triggers a temporary drop in the hormone progesterone. This shift may cause spotting, or even bleeding as heavy as a period. As long as the placenta begins producing enough progesterone, the pregnancy can safely continue, and a woman will not have a pregnancy loss.

Diagnosis

A doctor or other healthcare provider may do numerous tests to diagnose bleeding. These may include:

Ultrasound

A doctor may order an ultrasound to help diagnose a subchorionic hematoma.

An ultrasound can diagnose a subchorionic hematoma. It can also tell a healthcare provider the location of the pregnancy, helping in the detection of an ectopic pregnancy.

After about the 6th week of pregnancy, an ultrasound can measure the viability of the pregnancy. If the embryo is growing correctly, and there is a sufficiently strong heartbeat, this suggests that the pregnancy will continue and the risk of pregnancy loss is low.

An ultrasound can also examine other pelvic organs to check for causes of bleeding. For example, an ovarian cyst may cause bleeding.

Blood tests

Blood tests can measure levels of the pregnancy hormone hCG. Low hCG may suggest that a pregnancy is not developing correctly or is in its early stages.

Some healthcare providers also check progesterone levels. Low progesterone may cause temporary bleeding, while very low progesterone may be a sign of an abnormal pregnancy.

Is it normal?

While many women who experience bleeding have healthy pregnancies, it is important never to treat bleeding as usual. Bleeding can be a critical symptom of several pregnancy-related symptoms, and prompt treatment for conditions such as ectopic pregnancy can save lives.

Implantation bleeding

Implantation happens when a fertilized egg embeds in the lining of the uterus. This marks the beginning of pregnancy. Some women notice spotting shortly after implantation. However, the body does not begin producing hCG until after implantation.

A woman is not pregnant until after implantation, and a pregnancy test cannot usually detect pregnancy until several days after implantation. So, bleeding that appears after a woman already knows she is pregnant is not implantation bleeding.

Implantation bleeding is usually brown. Some women may mistake the bleeding for their monthly period because it usually occurs around the time a woman expects her period.

The flow of implantation bleeding is often lighter and shorter than a period, so women who experience unusual bleeding after having sex should consider the possibility of pregnancy.

When to see a doctor

Speak to a doctor about any bleeding early in pregnancy. While the bleeding may be harmless, it is impossible to diagnose its cause without blood work, an ultrasound, or other diagnostic tests.

Bleeding from a ruptured ectopic pregnancy can endanger the life of the mother. While many pregnancy losses pass on their own, some require treatment to prevent excessive bleeding and infection.

Prompt medical care can be lifesaving. Even when there is no serious problem, the right care can offer peace of mind.

If a pregnant woman experiencing spotting has Rh-negative blood, a doctor may prescribe RhoGAM. This treatment can help prevent a condition known as erythroblastosis fetalis.

If a woman experiences light bleeding at any time, they should contact a midwife, doctor, or another healthcare provider.

A woman should visit an emergency room if:

  • they develop a fever
  • bleeding gets heavier over several hours
  • bleeding is heavy, similar to a period
  • there are large clots in the blood
  • they have cramps
  • there is severe pain in the abdomen
  • they feel dizzy or light-headed

Summary

Many women panic when they bleed during pregnancy, especially if they have a previous history of miscarriage. Seeking prompt care is the fastest way to ease anxiety and get clear answers.

It is not advisable for people to try to self-diagnose bleeding or assume that bleeding means a pregnancy loss. A few quick tests can usually diagnose the cause, and prompt treatment can prevent possible complications.

Sleeping for less than 6 hours each night could put people with diabetes or hypertension at a higher risk of premature death.

A new study analyzing the data of more than 1,600 adults found that people with hypertension or type 2 diabetes had a higher risk of death from stroke or heart disease if they slept for less than 6 hours per night.

Type 2 diabetes and hypertension (high blood pressure) are two very common health conditions around the world.

While there are tried and true ways of managing them, these conditions can increase a person’s risk of developing heart disease and experiencing a stroke.

Recently, a study that featured in the Journal of the American Heart Association found that one factor — sleep — may play a significant role for people with these health conditions.

“Our study suggests that achieving normal sleep may be protective for some people with these health conditions and risks,” says lead author Julio Fernandez-Mendoza, Ph.D., from the Pennsylvania State College of Medicine in Hershey.

“However,” he cautions, “further research is needed to examine whether improving and increasing sleep through medical or behavioral therapies can reduce risk of early death.”

Is short sleep duration ‘a useful risk factor?’

In the new study, Fernandez-Mendoza and team analyzed the data of 1,654 participants — 52.5% of whom were women — between the ages of 20 and 74 years. All of the participants had enrolled in the Penn State Adult Cohort.

The researchers split the participants into two categories according to cardiometabolic risk. The participants in one group had stage 2 hypertension or type 2 diabetes, while those in the other group had received a diagnosis of or treatment for heart disease or stroke.

Moreover, the researchers had access to data regarding the participants’ sleep duration, as this cohort had agreed to a 1-night evaluation in a sleep laboratory between 1991 and 1998. They also had access to death records and associated documentation for the years from 1992 through to 2016.

The team’s analysis revealed that of the 512 people who had died by 2016, about two-fifths had died because of causes relating to heart disease or stroke, while close to one-quarter had died following a cancer diagnosis.

What caught the investigators’ attention was the fact that among individuals who had hypertension or type 2 diabetes, the risk of death due to heart disease or stroke was two times higher in those who slept for less than 6 hours per night than in those who slept for 6 hours or more.

For the individuals with one of these two health conditions who slept for longer, the increased risk of premature death was not significant.

Additionally, participants in the heart disease and stroke group who slept for less than 6 hours a night had almost three times the risk of dying from cancer-related causes.

“Short sleep duration should be included as a useful risk factor to predict the long term outcomes of people with these health conditions and as a target of primary and specialized clinical practices.

Julio Fernandez-Mendoza, Ph.D.

“I’d like to see policy changes so that sleep consultations and sleep studies become a more integral part of our healthcare systems. Better identification of people with specific sleep issues would potentially lead to improved prevention, more complete treatment approaches, better long term outcomes, and less healthcare usage,” suggests Fernandez-Mendoza.

While this research adds to the evidence that sleep plays a crucial role in the maintenance of health and well-being, the study authors do admit that their current analysis has some limitations.

The chief limitation, they note, is the fact that they only had access to data on the duration of a single night’s sleep.

As this data came from laboratory observations, they caution that there is a possibility that the participants’ normal sleep patterns may have been different than usual because they were in an unfamiliar environment.

“Nevertheless, the associations found for those other clustered non‐[cardiovascular and cerebrovascular disease] causes of death had the expected [hazard ratios] and provided confidence about the reliability and validity of our findings,” the authors argue in their study paper.